Screener
Avalo Therapeutics AVTX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from exercise of stock options | 7,409 | — |
| Cash paid related to withholding shares to satisfy RSU tax withholding obligations | (779) | (509) |
| Proceeds from issuance of common stock under employee stock purchase plan, net of cash paid related to withholding shares to satisfy tax withholding obligations | 66 | 40 |
| Net cash provided by (used in) financing activities | 411,608 | (469) |
| Increase (decrease) in cash, cash equivalents and restricted cash | 69,509 | (92,176) |
| Cash, cash equivalents, and restricted cash at beginning of period | 16,105 | 134,696 |
| Cash, cash equivalents, and restricted cash at end of period | $85,614 | $42,520 |
| Supplemental disclosures of non-cash activities |
Item 1. Financial Statements.
FAQ
- What is Avalo Therapeutics's financing cash flow?
- Avalo Therapeutics (AVTX) reported financing cash flow of $410.21M in Q2 2026.
- How has Avalo Therapeutics's financing cash flow changed year-over-year?
- Avalo Therapeutics's financing cash flow increased by 87564.6% year-over-year, from -$469K to $410.21M.
- What is the long-term trend for Avalo Therapeutics's financing cash flow?
- Over 2 years (2021 to 2025), Avalo Therapeutics's financing cash flow has grown at a -63.0% compound annual growth rate (CAGR), from $106.76M to $14.59M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Avalo Therapeutics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude